Type 2B von Willebrand Disease Evaluation

Clinical Presentation Supporting Type 2B VWD

A patient with a history of continuous bleeding following procedures, such as gum grafts and thyroidectomies, strongly suggests an underlying bleeding disorder, according to the American Journal of Hematology guidelines 1, 2
Intermittent thrombocytopenia is a hallmark feature of Type 2B VWD, as abnormal VWF spontaneously binds to platelets leading to their clearance, as noted by the American Journal of Hematology 3
Low ferritin levels likely reflect chronic blood loss due to the bleeding disorder, as reported by the American Journal of Hematology 1
A strong family history of bleeding problems across multiple generations supports an inherited bleeding disorder, according to the American Journal of Hematology 1

The patient's VWF antigen and activity levels appear normal but require careful interpretation, as stated by the American Journal of Hematology 3
The VWF:RCo/VWF:Ag ratio is 0.70, which is borderline for distinguishing Type 1 from Type 2 VWD, as noted by the American Journal of Hematology 3

VWF multimer analysis is recommended to assess the distribution of high molecular weight multimers, as suggested by the American Journal of Hematology 1, 3
Ristocetin-induced platelet aggregation (RIPA) at low concentrations of ristocetin is recommended to detect enhanced VWF-platelet binding, according to the American Journal of Hematology 1
Platelet VWF studies are recommended to evaluate platelet-VWF interactions, as reported by the American Journal of Hematology 1
Genetic sequencing of the VWF gene, particularly exon 28, is recommended to identify Type 2B mutations, as noted by the American Journal of Hematology 1

Blood samples for VWF assays must be properly collected and processed at room temperature to prevent cryoprecipitation of VWF, as stated by the American Journal of Hematology 2
Testing should be performed when the patient is not taking medications that affect platelet function, according to the American Journal of Hematology 1, 2

Diagnosis of Type 2B VWD would explain the patient's bleeding history and guide appropriate treatment for future procedures, as noted by the American Journal of Hematology 1

Type 2B VWD is typically characterized by VWF:RCo <30 IU/dL, VWF:Ag between 30-200 IU/dL, and a VWF:RCo/VWF:Ag ratio usually <0.5-0.7, according to the American Society of Hematology 4, 5, 6
Laboratory testing for VWD has relatively high coefficients of variation (10-30%), especially for the VWF:RCo assay, which can impact diagnostic accuracy 4
VWF is an acute phase reactant, and levels can vary in response to clinical status, potentially resulting in falsely elevated results, as noted by the American Academy of Pediatrics 7

Initial laboratory evaluation should include VWF:RCo, VWF:Ag, and FVIII levels, as recommended by the American Society of Hematology 8
If initial testing is normal but family history is positive for type 2B VWD, consider repeat testing up to 3 times due to variability in VWF levels, according to the American Academy of Pediatrics and other guidelines 7, 9
The American Society of Hematology recommends calculating the VWF:RCo/VWF:Ag ratio to distinguish between type 1 and type 2 VWD 9

Relying solely on VWF:RCo/VWF:Ag ratio without considering family history can lead to misdiagnosis, as cautioned by the American Society of Hematology 9
Failing to repeat testing when initial results are normal but clinical suspicion is high can also lead to misdiagnosis, according to the American Society of Hematology and the American Academy of Pediatrics 4, 7

The VWF:RCo/VWF:Ag ratio is 0.94, which is above the cutoff of <0.5-0.7 typically used to distinguish type 2 from type 1 VWD, as recommended by the American Society of Hematology 10
Recent surgical procedures may have elevated the patient's VWF levels as an acute phase reaction, potentially masking underlying VWD, according to the American Society of Hematology 11
Laboratory testing for VWD has high coefficients of variation (10-30%), especially for the VWF:RCo assay, which can impact diagnostic accuracy, as noted by the American Society of Hematology 10
Blood samples must be properly collected and processed at room temperature to prevent cryoprecipitation of VWF that could affect results, as recommended by the American Society of Hematology 11

A von Willebrand factor antigen level of 180% is within the normal reference range and does not indicate von Willebrand disease, according to the American Journal of Hematology guidelines 12
VWF:Ag is a laboratory measurement that quantifies the amount of von Willebrand factor protein in plasma, with normal values typically ranging from 50-200%, as stated by the American Journal of Hematology 12
Normal VWF:Ag levels generally exclude the diagnosis of type 1 and type 3 VWD, which are characterized by reduced or absent VWF protein, as per the American Journal of Hematology guidelines 12

VWF:Ag measurement alone is insufficient to diagnose or exclude all types of VWD, and additional tests such as VWF ristocetin cofactor activity and VWF multimer analysis may be needed, according to the American Journal of Hematology 12
Type 2 VWD may present with normal VWF:Ag levels but abnormal function, and the VWF:RCo/VWF:Ag ratio can be used to distinguish between type 1 and type 2 VWD, as stated by the American Journal of Hematology 12

A VWF:Ag level of 180% effectively rules out type 1 and type 3 VWD, according to the American Journal of Hematology guidelines 12
If there is clinical suspicion of a bleeding disorder despite normal VWF:Ag, consideration of type 2 VWD variants and evaluation of the VWF:RCo/VWF:Ag ratio may be necessary, as per the American Journal of Hematology guidelines 12